| Released | Contributor | Author | Title | Pages | Price |
| 24-Nov-2009 | Pechala's Reports | Lubomir Pechala | AFFYMAX INC (AFFY=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for AFFY | 13 |
$25 |
| 21-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: AFFYMAX INC | 5 |
$25 |
| 21-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| Affymax Inc | 5 |
$25 |
| 20-Nov-2009 | Pechala's Reports | Lubomir Pechala | AFFYMAX INC (AFFY=US) 2-weeks forecast | 1 |
$10 |
| 20-Nov-2009 | Pechala's Reports | Frantisek Pechala | AFFYMAX INC (AFFY=US) 12-months forecast | 1 |
$15 |
| 19-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ACOR , AFFY , ANDS , BSTC , OMPI , TELK -- DRUGS | 3 |
$4 |
| 19-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: AFFYMAX -- AFFY | 1 |
$4 |
| 19-Nov-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AFFYMAX INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
0.26% Nasdaq 
0.10 (0.48%) 
Research Reports
